SANA earnings: a negative outcome, -5.5%

On May 8, 2024, Sana Biotechnology, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.5% in the window around the event. It had already run +14.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.